Well-Differentiated Neuroendocrine Carcinomas: The Spectrum of Histologic Subtypes and Various Clinical Behaviors

Seminars in Thoracic and Cardiovascular Surgery

Volumn 18, Issue 3, 2006, Pages 199-205

  Warren, William H ^a   Welker, Michael ^a   Gattuso, Paolo ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

bronchial carcinoids; well differentiated neuroendocrine carcinoma

Indexed keywords

BOMBESIN; CALCITONIN; CHROMOGRANIN; CORTICOTROPIN; LEUCINE ENKEPHALIN; NEURON SPECIFIC ENOLASE; PROTEIN BCL 2; PROTEIN P53; SYNAPTOPHYSIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

APOPTOSIS; ARTICLE; BRONCHUS CARCINOID; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CLINICAL FEATURE; CYTOGENETICS; CYTOLOGY; FLOW CYTOMETRY; GENOMICS; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MITOSIS; NEUROENDOCRINE TUMOR; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA;

BRONCHIAL NEOPLASMS; CARCINOID TUMOR; CYTOGENETICS; FLOW CYTOMETRY; HUMANS; NEUROENDOCRINE TUMORS;

EID: 33845493247     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2006.08.008     Document Type: Article

References (59)

1. Oberndorfer S. Karzinoide Tumoren des Dunndarms. Frankf Z Pathol 1 (1907) 426-2
2. Hamperl H. Ueber gutartige Bronchialtumoren (Cylindrome und Carcinoide). Virchows Arch (Pathol Anat) 300 (1937) 46-88
3. Gould V.E., Linnoila R.I., Memoli V.A., et al. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest 49 (1983) 519-537
4. Mark E.J., and Rameriez J.F. Peripheral small cell carcinoma of the lung resembling carcinoid tumor: a clinical and pathologic study of 14 cases. Arch Pathol Lab Med 109 (1985) 263-269
5. Craig I.D., and Finley R.J. Spindle-cell carcinoid of the lung. Cytologic, histologic, and ultrastructural features. Acta Cytol 26 (1982) 495-498
6. Gillespie J.J., Luger A.M., and Callaway L.A. Peripheral spindle carcinoid tumor: a review of its ultrastructure, differential diagnosis, and biologic behaviour. Hum Pathol 10 (1979) 601-606
7. Arrigoni M.G., Woolner L.B., and Bernatz P.E. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64 (1972) 413-421
8. Warren W.H., and Gould V.E. Differential diagnosis of small cell neuroendocrine carcinoma of the lung. Chest Surg Clin N Am 7 (1997) 49-63
9. Warren W.H., Memoli V.A., Jordan A.G., et al. Reevaluation of pulmonary neoplasms resected as small cell carcinomas. Significance of distinguishing between well-differentiated and small cell neuroendocrine carcinomas. Cancer 65 (1990) 1003-1010
10. Warren W.H., Memoli V.A., and Gould V.E. Well-differentiated and small cell neuroendocrine carcinomas of the lung. Two related but distinct clinicopathologic entities. Virchows Arch 55 (1988) 299-310
11. Lequaglie C., Patriarca C., Cataldo I., et al. Prognosis of resected well-differentiated neuroendocrine carcinoma of the lung. Chest 100 (1991) 1053-1056
12. Memoli V.A. Well-differentiated neuroendocrine carcinoma. A designation comes of age. Chest 100 (1991) 892
13. Youssem S.A. Pulmonary carcinoid tumors and well-differentiated neuroendocrine carcinomas. Is there room for an atypical carcinoid?. Am J Clin Pathol 95 (1991) 763-764
14. Jordan A.G., Predmore L., Sullivan M.M., et al. The cytodiagnosis of well differentiated neuroendocrine carcinoma: a distinct clinicopathologic entity. Acta Cytol 31 (1987) 464-470
15. Frierson H.F., Covell J.L., and Mills S.E. Fine needle aspiration cytology of atypical carcinoid of the lung. Acta Cytol 31 (1987) 471-475
16. Nicholson S.A., and Ryan M.R. A review of cytologic findings in neuroendocrine carcinomas including carcinoid tumors with histologic correlation. Cancer 90 (2000) 148-161
17. Collins B.T., and Cramer H.M. Fine needle aspiration cytology of carcinoid tumors. Acta Cytol 40 (1996) 695-707
18. Gephardt G.N., and Belovich D.M. Cytology of pulmonary carcinoid tumors. Acta Cytol 26 (1982) 434-438
19. Capelozzi V.L., Battlehner C.N., Montes G.S., et al. Volume fraction of dense-core granules correlates strongly with survival in disseminated (Stage IV) neuroendocrine cell carcinomas of the lung of the well differentiated and small cell subtypes. Pathol Res Pract 189 (1993) 1145-1148
20. Pilotti S., Patrirca C., Lombardi L., et al. Well-differentiated neuroendocrine carcinoma of the lung: a clinicopathologic and ultrastructural study of 10 cases. Tumori 78 (1992) 121-129
21. Valli M., Fabris G.A., Dewar A., et al. Atypical carcinoid tumor of the lung: a study of 33 cases with prognostic features. Histopathology 24 (1994) 363-369
22. Warren W.H., and Gould V.E. Long-term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations. Scand J Thor Cardiovasc Surg 24 (1990) 125-130
23. Gosney J.R., and Denley R.M. Sustentacular cells in pulmonary neuroendocrine tumors. Histopathology 34 (1999) 211-215
24. Chong S., Lee K.S., Chung M.J., et al. Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radiographics 26 (2006) 41-57
25. Ferguson M.F., Landreneau R.J., Hazelrigg S.R., et al. Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg 18 (2000) 156-161
26. Daddi N., Ferolla P., Urbani M., et al. Surgical treatment of neuroendocrine tumors of the lung. Eur J Cardiothorac Surg 26 (2004) 813-817
27. Marty-Ane C.H., Costes V., Pujol J.L., et al. Carcinoid tumors of the lung: do atypical features require aggressive management?. Ann Thorac Surg 59 (1995) 78-83
28. Kaplan B., Stevens C.W., Allen P., et al. Outcomes and patterns of failure in bronchial carcinoid tumors. Int J Radiat Oncol Biol Phys 55 (2003) 125-131
29. Garcia-Yuste M., Matilla J.M., Alvarez-Gago T., et al. Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study. Ann Thorac Surg 70 (2000) 258-263
30. Warren W.H., and Gould V.E. Neuroendocrine tumors of the bronchopulmonary tract. A reappraisal of their classification after 20 years. Surg Clin N Am 82 (2002) 525-540
31. Beasley M.B., Thunnissen B.J.M., Brambilla E., et al. Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 31 (2000) 1255-1265
32. Travis W.D., Rush W., Flieder D.B., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22 (1998) 934-944
33. Chakravarthy A., and Abrams R.A. Radiation therapy in the management of patients with malignant carcinoid. Cancer 75 (1995) 1386-1390
34. Cooper W.A., Thourani V.H., Gal A.A., et al. The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 119 (2001) 14-18
35. Colleoni M., Di Bartolomeo M., Patriarca C., et al. Well-differentiated neuroendocrine carcinoma of the lung: a case report. Tumori 77 (1991) 282-284
36. Musi M., Carbone R.G., Bertocchi C., et al. Bronchial carcinoid tumors: a study of clinicopathologic features and the role of octreotide scintigraphy. Lung Cancer 22 (1998) 97-102
37. Filosso P.L., Croce S., Oliaro A., et al. Long-term survival of patients treated with octreotide for metastatic well differentiated neuroendocrine carcinoma of the lung. J Cardiovasc Surg 41 (2000) 773-776
38. Thomas C.F., Tazelaar H.D., and Jett J.R. Typical and atypical pulmonary carcinoids. Outcome in patients presenting with regional lymph node involvement. Chest 119 (2001) 1143-1150
39. Perkins P., Kemp B., and Putnam. Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behaviour. Am J Clin Oncol 20 (1997) 285-288
40. Soga J., and Yakuwa Y. Bronchopulmonary carcinoids: an analysis of 1875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 5 (1999) 211-219
41. Shah R., Sabanathan S., Mearns J., et al. Carcinoid tumours of the lung. J Cardiovasc Surg 38 (1997) 187-189
42. Jackson-York G.L., Davis B.H., Warren W.H., et al. Flow cytometric DNA content analysis in neuroendocrine carcinoma of the lung. Correlation with survival and histologic subtype. Cancer 68 (1991) 374-379
43. Rusch V.W., Klimstra D.S., and Venkatramam E.S. Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 62 (1996) 798-810
44. Zirbes T.K., Lorenzen J., Baldus S.E., et al. Apoptosis and expression of bcl-2 protein are inverse factors influencing tumour cell turnover in primary carcinoid tumors of the lung. Histopathology 33 (1998) 123-128
45. Costes V., Mary-Ane C., Picot M.C., et al. Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and Ki-67-labelling study. Hum Pathol 26 (1995) 740-745
46. Sampietro G., Tomasic G., Collini P., et al. Gene product immunotyping of neuroendocrine lung tumors. No link evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Appl Immunohistochem Mol Morphol 8 (2000) 49-56
47. Arbiser Z.K., Arbiser J.L., Cohen C., et al. Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis. Mod Pathol 14 (2001) 1195-1199
48. Gugger M., Burckhardt E., Kappeler A., et al. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung tumors. J Pathol 196 (2002) 408-415
49. Wang D.-G., Johnston C.F., Sloan J.M., et al. Expression of Bcl-2 in lung neuroendocrine tumors: comparison with p53. Am J Surg Pathol 22 (1998) 934-944
50. Santinelli A., Ranaldi R., Baccarini M., et al. Ploidy, proliferative activity, p53, and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis. Pathol Res Pract 195 (1999) 467-474
51. Jiang S.X., Kameya T., Sat U., et al. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Am J Pathol 148 (1996) 837-846
52. Brambilla E., Negoescu A., Gazzeri S., et al. Apoptosis-related factors p53, Bcl-2, and Bax in neuroendocrine lung tumors. Am J Pathol 149 (1996) 1941-1952
53. Gomez-Roman J.J., Romero A.F., Castro L.S., et al. Telomerase activity in pulmonary neuroendocrine tumors. Correlation with histologic subtype (MS-0060). Am J Surg Pathol 24 (2000) 417-421
54. Onuki N., Wistuba I.I., Travis W.D., et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 85 (1999) 600-607
55. Debelenko L.V., Swalwell J.I., Kelley M.J., et al. Genes chromosomes. Cancer 28 (2000) 58-65
56. Petzmann S., Ullmann R., Klemen H., et al. Loss of heterozygosity on chromosome arm 11q in lung carcinoids. Hum Pathol 32 (2001) 333-338
57. Walch A.K., Zitzelsberger H.F., Aubele M.M., et al. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 153 (1998) 1089-1098
58. Ullmann R., Schwendel A., Klemen H., et al. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization. Hum Pathol 29 (1998) 1145-1149
59. Przygodzki R.M., Finkelstein S.D., Langer J.C., et al. Analysis of p53, K-ras-2, and c-raf-1 in pulmonary neuroendocrine tumors. Correlation with histologic subtype and clinical outcome. Am J Pathol 148 (1996) 1531-1541